Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Vycor Medical Inc (QB) | VYCO | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.09 | 0.09 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.0423 - 0.1279 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.09 | USD |
Vycor Medical Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.94M | 32.68M | 12.13M | 1.46M | -394k | -0.01 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vycor Medical (QB) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VYCO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.10 | 0.10 | 0.09 | 0.0938095 | 1,050 | -0.01 | -10.00% |
1 Month | 0.061 | 0.1279 | 0.061 | 0.1125241 | 5,732 | 0.029 | 47.54% |
3 Months | 0.061 | 0.1279 | 0.061 | 0.1006658 | 5,420 | 0.029 | 47.54% |
6 Months | 0.057 | 0.1279 | 0.0423 | 0.0847004 | 11,681 | 0.033 | 57.89% |
1 Year | 0.08 | 0.1279 | 0.0423 | 0.085627 | 12,844 | 0.01 | 12.50% |
3 Years | 0.13625 | 0.279 | 0.0301 | 0.106679 | 23,813 | -0.04625 | -33.94% |
5 Years | 0.0736 | 0.51 | 0.0102 | 0.1205582 | 20,935 | 0.0164 | 22.28% |
Vycor Medical (QB) Description
Vycor is dedicated to providing the medical community with innovative and superior neurosurgical and neurotherapeutic solutions and operates two distinct business units within the medical industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision develops non-invasive, computer-based light stimulation therapies for those suffering from vision loss resulting from neurological trauma |